1. Bioequivalence and Bio-weivar study:
- Bioequivalence is a term in pharmacokinetics used to assess the expected in vivo biological equivalence of two proprietary preparations of a drug. If two products are said to be bioequivalent it means that they would be expected to be, for all intents and purposes, the same.
- A Biowaiver means that in vivo bioavailability and/or bioequivalence studies may be waived (not considered necessary for product approval). Instead of conducting expensive and time consuming in vivo studies, a dissolution test could be adopted as the surrogate basis for the decision as to whether the two pharmaceutical products are equivalent.
- MSA bioequivalence center have all facilities and equipment required to undergo steps of Biowaiver and Bioequivalence study
2. Analytical Research:
- Research Service support and enhance the research, education, and public service missions of the University by providing access to characterization and process instrumentation.
- Staff provides the assistance and guidance necessary so that students, faculty, and industry get the most effective and appropriate use of the center's facilities.
Is the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product.
Bioequivalence Center - Contacts
26 July Mehwar Road intersection with Wahat Road, 6th October City. Egypt.
Tel. : (+202) 38371534-5-7/ Ext: 5146
Fax : (+202) 38371534-5-7 /Ext: 5143
Hotline : 16672